Author Correction: ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer

Bibliographic Details
Published in:	Communications Medicine
Main Authors:	Rodney P. Rocconi, Laura Stanbery, Min Tang, Luciana Madeira da Silva, Adam Walter, Bradley J. Monk, Thomas J. Herzog, Robert L. Coleman, Luisa Manning, Gladice Wallraven, Staci Horvath, Ernest Bognar, Neil Senzer, Scott Brun, John Nemunaitis
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-05-01
Online Access:	https://doi.org/10.1038/s43856-023-00290-0

Similar Items

ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer
by: Rodney P. Rocconi, et al.
Published: (2022-08-01)

Long-Term Follow-Up of Gemogenovatucel-T (Vigil) Survival and Molecular Signals of Immune Response in Recurrent Ovarian Cancer
by: Rodney P. Rocconi, et al.
Published: (2021-08-01)

Corrigendum to “Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance” [Gynecol. Oncol. Rep. 34 (2020) 100648]
by: Jonathan Oh, et al.
Published: (2021-05-01)

Case Report: Marked Survival Advantage of Two Colorectal Cancer Patients with Liver Metastases Treated with Vigil and FOLFOX-6
by: Vedin Barve, et al.
Published: (2021-10-01)

Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil product
by: David Willoughby, et al.
Published: (2025-03-01)

Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer
by: John Nemunaitis, et al.
Published: (2023-09-01)

Evaluation of variants in the ENTPD1 and ENTPD2 genes in athletic horses with exercise-induced pulmonary haemorrhage
by: Raíssa Oliveira Leite, et al.
Published: (2024-08-01)

Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma
by: David Kung-Chun Chiu, et al.
Published: (2017-09-01)

Efficacy and safety of Gemogenovatucel-T (Vigil) immunotherapy for advanced ovarian carcinoma: A systematic review and meta-analysis of randomized controlled trials
by: Yixin Zhang, et al.
Published: (2022-10-01)

Identifying small molecule probes of ENTPD5 through high throughput screening.
by: Matthew A Durst, et al.
Published: (2019-01-01)

by: Yuqiao Shen, et al.
Published: (2008-04-01)

Hepatic ENTPD5 Is Critical for Maintaining Metabolic Homeostasis and Promoting Brown Adipose Tissue Thermogenesis
by: Rufeng Ma, et al.
Published: (2025-10-01)

Bioinformatics-based identification of CTSS, DOK2, and ENTPD1 as potential blood biomarkers of schizophrenia
by: Lei Zhang, et al.
Published: (2025-02-01)

Identification of ENTPD1 as a novel biomarker linking allergic rhinitis and systemic lupus erythematosus
by: Min Chen, et al.
Published: (2024-08-01)

ENTPD5 induces apoptosis in lung cancer cells via regulating caspase 3 expression.
by: Yijun Xue, et al.
Published: (2015-01-01)

The UDPase ENTPD5 regulates ER stress-associated renal injury by mediating protein N-glycosylation
by: Lifen Xu, et al.
Published: (2023-02-01)

Endothelial Effects of Simultaneous Expression of Human HO-1, E5NT, and ENTPD1 in a Mouse
by: Paulina Mierzejewska, et al.
Published: (2023-10-01)

p53 gain-of-function mutations promote metastasis via ENTPD5 upregulation and enhanced N-glycoprotein folding
by: Oleg Timofeev, et al.
Published: (2017-03-01)

PTEN phosphatase inhibits metastasis by negatively regulating the Entpd5/IGF1R pathway through ATF6
by: Yanlin Yu, et al.
Published: (2023-02-01)

Inhibition of lung cancer cells and Ras/Raf/MEK/ERK signal transduction by ectonucleoside triphosphate phosphohydrolase-7 (ENTPD7)
by: Zhongwei Wen, et al.
Published: (2019-08-01)

HER2-positive metastatic cervical cancer responsive to first and second-line treatment: A case report
by: Dylan Fortman, et al.
Published: (2020-02-01)

Tumor derived exosomal ENTPD2 impair CD8+ T cell function in colon cancer through ATP-adenosine metabolism reprogramming
by: Mengchen Shi, et al.
Published: (2024-05-01)

KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex.
by: Donald D Rao, et al.
Published: (2018-01-01)

Systemic benefit of radiation therapy via abscopal effect
by: Daniel J. Craig, et al.
Published: (2022-10-01)

Retraction Note: Circular RNA ATXN7 promotes the development of gastric cancer through sponging miR-4319 and regulating ENTPD4
by: Zhen Zhang, et al.
Published: (2025-03-01)

RETRACTED ARTICLE: Circular RNA ATXN7 promotes the development of gastric cancer through sponging miR-4319 and regulating ENTPD4
by: Zhen Zhang, et al.
Published: (2020-01-01)

ENTPD8 overexpression enhances anti-PD-L1 therapy in hepatocellular carcinoma via miR-214-5p inhibition
by: Si-qi Zhao, et al.
Published: (2025-02-01)

Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
by: Evangelos Pavlakis, et al.
Published: (2023-08-01)

3D engineered scaffold for large-scale Vigil immunotherapy production
by: Fabienne Kerneis, et al.
Published: (2024-07-01)

A Scalable Engineered Extracellular Matrix Platform to Expand Tumor Cells
by: Seongjun Moon, et al.
Published: (2023-08-01)

Simultaneous Overexpression of Functional Human HO-1, E5NT and ENTPD1 Protects Murine Fibroblasts against TNF-α-Induced Injury In Vitro.
by: Alessandro Cinti, et al.
Published: (2015-01-01)

Adenomatous polyposis coli in cancer and therapeutic implications
by: Olivia Noe, et al.
Published: (2021-06-01)

Adaptation and validation of the Hungarian version of Thyroid-Related Patient-Reported Outcome-39 (ThyPro-39) questionnaire: testing factor structure, known-group validity with the comparison of quality of life in Hashimoto’s thyroiditis and Graves’ disease
by: Adrien Rigó, et al.
Published: (2023-06-01)

Impact of Vitamin D deficiency on immunological and metabolic responses in women with recurrent pregnancy loss: focus on VDBP/HLA-G1/CTLA-4/ENTPD1/adenosine-fetal-maternal conflict crosstalk
by: Aisha Nawaf Al Balawi, et al.
Published: (2024-10-01)

Commentary on ''Force-field functor theory: classical force-fields which reproduce equilibrium quantum distributions''
by: Ruggero eVaia
Published: (2013-12-01)

Asugyafoɔ (Unmarried) and Akunafoɔ (Widows) in 1 Corinthians 7:8-9, 39-40: An Akan Christian Perspective
by: Ernest Nyarko
Published: (2025-03-01)

Volume 39
by: Revista Alfa
Published: (2001-02-01)

['Lógoi Magazine N°39', 'Revista Lógoi N°39']
by: María Aurelia Delgado Mansilla
Published: (2021-06-01)

Enhancing 'theory of mind' through behavioral synchrony
by: Adam eBaimel, et al.
Published: (2015-06-01)

Towards a 'canonical' agranular cortical microcircuit
by: Sarah F. Beul, et al.
Published: (2015-01-01)